CNS elevation of vascular and not mucosal addressin cell adhesion molecules in patients with multiple sclerosis

American Journal of Pathology

Volumn 176, Issue 2, 2010, Pages 556-562

  Allavena, Rachel ^a   Noy, Suzanna ^a   Andrews, Marcus ^a   Pullen, Nick ^a  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MUCOSAL ADDRESSIN CELL ADHESION MOLECULE 1; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; BRAIN TISSUE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; ENDOTHELIUM CELL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LEUKOCYTE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 76149144033     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2010.090437     Document Type: Article

References (29)

1. Hafler DA, Slavik JM, Anderson DE, O'Connor KC, De Jager P, Baecher-Allan C: Multiple sclerosis. Immunol Rev 2005, 204:208-231
2. McFarland HF, Martin R: Multiple sclerosis: a complicated picture of autoimmunity. Nat Immunol 2007, 8:913-919
3. Khalili K, White MK, Lublin F, Ferrante P, Berger JR: Reactivation of JC virus and development of PML in patients with multiple sclerosis. Neurology 2007, 68:985-990
4. Van Assche G, Van Ranst M, Sciot R, Dubois B, Vermeire S, Noman M, Verbeeck J, Geboes K, Robberecht W, Rutgeerts P: Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease. N Engl J Med 2005, 353:362-368
5. Freim Wahl SG, Folvik MR, Torp SH: Progressive multifocal leukoencephalopathy in a lymphoma patient with complete remission after treatment with cytostatics and rituximab: case report and review of the literature. Clin Neuropathol 2007, 26:68-73
6. Yokoyama H, Watanabe T, Maruyama D, Kim SW, Kobayashi Y, Tobinai K: Progressive multifocal leukoencephalopathy in a patient with B-cell lymphoma during rituximab-containing chemotherapy: case report and review of the literature. Int J Hematol 2008, 88:443-447
7. Berger JR, Houff S: Progressive multifocal leukoencephalopathy: lessons from AIDS and natalizumab. Neurol Res 2006, 28:299-305
8. Brooks BR, Walker DL: Progressive multifocal leukoencephalopathy. Neurol Clin 1984, 2:299-313
9. Taguchi F, Kajioka J, Miyamura T: Prevalence rate and age of acquisition of antibodies against JC virus and BK virus in human sera. Microbiol Immunol 1982, 26:1057-1064
10. Pullen N, Molloy E, Carter D, Syntin P, Clemo F, Finco-Kent D, Reagan W, Zhao S, Kawabata T, Sreckovic S: Pharmacological characterisation of PF-00547659, an anti-human MAdCAM monoclonal antibody. Br J Pharmacol 2009, 157:281-293
11. Briskin M, Winsor-Hines D, Shyjan A, Cochran N, Bloom S, Wilson J, McEvoy LM, Butcher EC, Kassam N, Mackay CR, Newman W, Ringler DJ: Human mucosal addressin cell adhesion molecule-1 is preferentially expressed in intestinal tract and associated lymphoid tissue. Am J Pathol 1997, 151:97-110
12. Oshima T, Pavlick KP, Laroux FS, Verma SK, Jordan P, Grisham MB, Williams L, Alexander JS: Regulation and distribution of MAd-CAM-1 in endothelial cells in vitro. Am J Physiol Cell Physiol 2001, 281:C1096-C1105
13. Leung E, Greene J, Ni J, Raymond LG, Lehnert K, Langley R, Krissansen GW: Cloning of the mucosal addressin MAdCAM-1 from human brain: identification of novel alternatively spliced transcripts. Immunol Cell Biol 1996, 74:490-496
14. Steffen BJ, Breier G, Butcher EC, Schulz M, Engelhardt B: ICAM-1. VCAM-1, and MAdCAM-1 are expressed on choroid plexus epithelium but not endothelium and mediate binding of lymphocytes in vitro. Am J Pathol 1996, 148:1819-1838
15. Kanwar JR, Harrison JE, Wang D, Leung E, Mueller W, Wagner N, Krissansen GW: Beta7 integrins contribute to demyelinating disease of the central nervous system. J Neuroimmunol 2000, 103:146-152
16. Kanwar JR, Kanwar RK, Krissansen GW: Simultaneous neuroprotection and blockade of inflammation reverses autoimmune encephalomyelitis. Brain 2004, 127:1313-1331
17. Kanwar JR, Kanwar RK, Wang D, Krissansen GW: Prevention of a chronic progressive form of experimental autoimmune encephalomyelitis by an antibody against mucosal addressin cell adhesion molecule-1, given early in the course of disease progression. Immunol Cell Biol 2000, 78:641-645
18. Leung ELKB, Kanwar JR, Yang YMYMH, Patrick; Krissansen GW: Bioassay detects soluble MAdCAM-1 in body fluids. Immunol Cell Biol 2004, 82:400-409
19. Raine CS: Demyelinating diseases. Edited by RL Davis, DM Robertson. London, Williams and Wilkins, 1985, pp. 468-547
20. Koizumi M, King N, Lobb R, Benjamin C, Podolsky DK: Expression of vascular adhesion molecules in inflammatory bowel disease. Gastroenterology 1992, 103:840-847
21. Matsuzaki K, Tsuzuki Y, Matsunaga H, Inoue T, Miyazaki J, Hokari R, Okada Y, Kawaguchi A, Nagao S, Itoh K, Matsumoto S, Miura S: In vivo demonstration of T lymphocyte migration and amelioration of ileitis in intestinal mucosa of SAMP1/Yit mice by the inhibition of MAdCAM-1. Clin Exp Immunol 2005, 140:22-31
22. Engelhardt B, Conley FK, Kilshaw PJ, Butcher EC: Lymphocytes infiltrating the CNS during inflammation display a distinctive phenotype and bind to VCAM-1 but not to MAdCAM-1. Int Immunol 1995, 7:481-491
23. Engelhardt B, Laschinger M, Schulz M, Samulowitz U, Vestweber D, Hoch G: The development of experimental autoimmune encephalomyelitis in the mouse requires alpha4-integrin but not alpha4beta7-integrin. J Clin Invest 1998, 102:2096-2105
24. Soilu-Hanninen M, Roytta M, Salmi A, Salonen R: Therapy with antibody against leukocyte integrin VLA-4 (CD49d) is effective and safe in virus-facilitated experimental allergic encephalomyelitis. J Neuroimmunol 1997, 72:95-105
25. Theien BE, Vanderlugt CL, Eagar TN, Nickerson-Nutter C, Nazareno R, Kuchroo VK, Miller SD: Discordant effects of anti-VLA-4 treatment before and after onset of relapsing experimental autoimmune encephalomyelitis. J Clin Invest 2001, 107:995-1006
26. Goodin DS, Cohen BA, O'Connor P, Kappos L, Stevens JC: Assessment: the use of natalizumab (Tysabri) for the treatment of multiple sclerosis (an evidence-based review): Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2008, 71:766-773
27. Connor EM, Eppihimer MJ, Morise Z, Granger DN, Grisham MB: Expression of mucosal addressin cell adhesion molecule-1 (MAdCAM-1) in acute and chronic inflammation. J Leukoc Biol 1999, 65:349-355
28. Wang X, Michie SA, Xu B, Suzuki Y: Importance of IFN-gammamediated expression of endothelial VCAM-1 on recruitment of CD8+ T cells into the brain during chronic infection with Toxoplasma gondii. J Interferon Cytokine Res 2007, 27:329-338
29. Vercellino M, Votta B, Condello C, Piacentino C, Romagnolo A, Merola A, Capello E, Mancardi GL, Mutani R, Giordana MT, Cavalla P: Involvement of the choroid plexus in multiple sclerosis autoimmune inflammation: a neuropathological study. J Neuroimmunol 2008, 199:133-141